Two Sigma Investments’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-126,602
Closed -$265K – 5397
2026
Q2
$265K Buy
126,602
+98,962
+358% +$195K ﹤0.01% 4611
2026
Q1
$48.4K Hold
27,640
– – ﹤0.01% 4455
2025
Q4
$65K Buy
+27,640
New +$53.1K ﹤0.01% 3902
2023
Q1
– Sell
-693
Closed -$54.1K – 3147
2022
Q4
$54.1K Buy
693
+586
+548% +$34K ﹤0.01% 2581
2022
Q3
$8K Buy
+107
New +$22.7K ﹤0.01% 2419
2022
Q2
– Sell
-29
Closed -$23K – 2833
2022
Q1
$23K Buy
29
+10
+53% +$8.08K ﹤0.01% 2522
2021
Q4
$19K Buy
+19
New +$33.2K ﹤0.01% 4174

Other funds holding PALI

Two Sigma Investments's PALI Position: Q3 2026 in Review

Two Sigma Investments sold out of Palisade Bio (PALI) in Q3 2026, closing a stake of 126,602 shares — an estimated $265K sold.

Two Sigma Investments first reported a position in PALI in Q4 2021 and held it in 7 quarters. The position peaked at $265K in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Two Sigma Investments reported no remaining Palisade Bio position as of Q3 2026 after selling out during the quarter.
  • Two Sigma Investments sold 126,602 Palisade Bio shares in Q3 2026, an estimated $265K.
  • Two Sigma Investments first reported a position in Palisade Bio in Q4 2021 and held it in 7 quarters.
  • Two Sigma Investments's Palisade Bio position peaked at $265K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.